| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;74:378-383
© 2002 The Society of Thoracic Surgeons
a Department of Cardiac Surgery, Tor Vergata University of Rome, Rome, Italy
b 2nd University of Naples, Naples, Italy
Accepted for publication April 21, 2002.
* Address reprint requests to Dr Nardi, Tor Vergata University of Rome, European Hospital, Via Portuense 700, 00149 Rome, Italy
Abstract
Background. The incremental surgical risk caused by different categories of renal failure is not well defined.
Methods. Data from 159 patients with moderate to end-stage renal dysfunction, who had consecutive operations using cardiopulmonary bypass, were included in a multivariate analysis of morbidity and survival. Ninety-nine patients had preoperative serum creatinine levels (PSCL) of 1.9 to 2.5 mg/dL (moderate), 36 had PSCL higher than 2.5 mg/dL and were not dialysis dependent (severe), and 24 required chronic dialysis (end-stage dysfunction).
Results. Operative mortality was 4% with moderate dysfunction and compared favorably with 16.7% in severe and 8% in end-stage dysfunction (p < 0.05). Independent predictors of death were severe non-dialysis-dependent renal dysfunction (p < 0.05), diabetes (p < 0.05), and cardiopulmonary bypass time (p < 0.01). Severe renal dysfunction (p < 0.01) and diabetes (p < 0.01) also predicted pulmonary and neurologic morbidity. Freedom from late death at 4 years was 82% ± 5% with moderate, 49% ± 10% with severe, and 60% ± 10% with end-stage dysfunction (p < 0.01). Time to late death was adversely affected by severe (p < 0.05) and end-stage dysfunction (p < 0.01). Persistent improvement of symptoms was observed in all subgroups.
Conclusions. Satisfactory early and late surgical outcomes may be expected in patients with moderate renal failure, but outcomes are often poor with severe non-dialysis-dependent and end-stage renal dysfunction.
This article has been cited by other articles:
|
|
 |
|
  F. Filsoufi, J. Chikwe, J. G. Castillo, P. B. Rahmanian, J. Vassalotti, and D. H. Adams Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3613 - 3621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ledoux, M. Monchi, J.-P. Chapelle, and P. Damas Cystatin C blood level as a risk factor for death after heart surgery Eur. Heart J., August 1, 2007; 28(15): 1848 - 1853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Devbhandari, A. J. Duncan, A. D. Grayson, B. M. Fabri, D. J.M. Keenan, B. Bridgewater, M. T. Jones, J. Au, and On behalf of the North West Quality Improvement Pr Effect of risk-adjusted, non-dialysis-dependent renal dysfunction on mortality and morbidity following coronary artery bypass surgery: a multi-centre study. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 964 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Chan, W.R. E. Jamieson, A. G. Fleisher, D. Denmark, F. Chan, and E. Germann Valve Replacement Surgery in End-Stage Renal Failure: Mechanical Prostheses Versus Bioprostheses. Ann. Thorac. Surg., March 1, 2006; 81(3): 857 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Witczak, A. Hartmann, and J. L. Svennevig Multiple Risk Assessment of Cardiovascular Surgery in Chronic Renal Failure Patients Ann. Thorac. Surg., April 1, 2005; 79(4): 1297 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Antunes, D. Prieto, J. F. de Oliveira, and M. J. Antunes Renal dysfunction after myocardial revascularization Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 597 - 604. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
